AVP Receptor V1a Activators
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Felypressin Acetate | 914453-97-7 | sc-497815 | 5 mg | $380.00 | ||
Felypressin Acetate acts as a selective agonist for the AVP receptor V1A, engaging in specific molecular interactions that stabilize receptor activation. Its binding induces conformational changes that enhance G-protein coupling, leading to distinct intracellular signaling pathways. The compound's unique structure facilitates interactions with membrane lipids, influencing receptor localization and activity. This modulation of signaling dynamics plays a crucial role in various physiological processes. | ||||||
Desmopressin | 16679-58-6 | sc-391126 | 1 mg | $138.00 | ||
A synthetic analog of AVP, Desmopressin mimics the endogenous ligand's action and directly activates AVP Receptor V1a. This activation results in the modulation of cellular responses associated with AVP Receptor V1a signaling pathways. | ||||||
Lypressin | 50-57-7 | sc-279284 | 5 mg | $190.00 | ||
Lypressin, a synthetic vasopressin analog, directly activates AVP Receptor V1a, initiating intracellular events that modulate cellular processes associated with the receptor. The activation of AVP Receptor V1a by Lypressin mirrors the endogenous ligand′s action. | ||||||
Vasopressin | 11000-17-2 | sc-356188 sc-356188A | 5 mg 25 mg | $260.00 $1040.00 | 1 | |
Vasopressin, an endogenous hormone, directly activates AVP Receptor V1a, influencing downstream signaling pathways. The binding of Vasopressin to the receptor leads to the modulation of cellular processes associated with AVP Receptor V1a activation. | ||||||
Phorbol-12,13-dibutyrate | 37558-16-0 | sc-202285 | 1 mg | $124.00 | 3 | |
A diacylglycerol (DAG) analog that activates protein kinase C (PKC), influencing pathways linked to AVP Receptor V1a. The activation of PKC can modulate downstream signaling cascades, indirectly promoting AVP Receptor V1a activity through PKC-mediated pathways. | ||||||
Prostaglandin F2α | 551-11-1 | sc-203219 | 1 mg | $88.00 | 1 | |
An endogenous prostaglandin that can activate phospholipase C (PLC), indirectly influencing AVP Receptor V1a. Activation of PLC can modulate downstream signaling cascades, leading to alterations in cellular processes associated with AVP Receptor V1a activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inhibitor of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), indirectly influencing AVP Receptor V1a. Inhibition of SERCA leads to disruption in calcium homeostasis, potentially modulating cellular responses associated with AVP Receptor V1a activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of mitogen-activated protein kinase kinase (MEK), indirectly influencing AVP Receptor V1a. Inhibition of MEK disrupts the MAPK signaling pathway, potentially modulating cellular responses associated with AVP Receptor V1a activation. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $510.00 | ||
A Gq protein inhibitor that indirectly influences AVP Receptor V1a signaling. Inhibition of Gq proteins can impact downstream pathways, potentially leading to alterations in cellular processes associated with AVP Receptor V1a activation. | ||||||